These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10980216)

  • 1. Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction.
    Kermani M; Dua A; Gradman AH
    Am J Cardiol; 2000 Sep; 86(6):644-8. PubMed ID: 10980216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
    Rangaswamy C; Finn JI; Koelling TM
    Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
    Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
    Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1998 Jun; 46(6):751-2. PubMed ID: 9625192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
    Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
    South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
    Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
    Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.
    Philbin EF
    Clin Cardiol; 1998 Feb; 21(2):103-8. PubMed ID: 9491949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of chronic therapy with low dose of angiotensin converting enzyme inhibitors on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Goch JH; Chizyński K
    Pol Merkur Lekarski; 2006 Apr; 20(118):395-8. PubMed ID: 16886559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
    McDermott MM; Lee P; Mehta S; Gheorghiade M
    Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators.
    de Kam PJ; Voors AA; van den Berg MP; van Veldhuisen DJ; Brouwer J; Crijns HJ; Borghi C; Ambrosioni E; Hochman JS; LeJemtel TH; Kingma JH; Sutton MS; van Gilst WH
    J Am Coll Cardiol; 2000 Dec; 36(7):2047-53. PubMed ID: 11127439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function.
    Reikvam A; Kvan E; Landmark K; Aursnes I;
    Scand Cardiovasc J; 2003 Jun; 37(3):130-4. PubMed ID: 12881153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.